COVID-19 vaccine in India, the Economic Times reported on Monday.Tata Medical & Diagnostics could team up with the India's Council of Scientific and Industrial Research to carry out clinical trials of Moderna's vaccine candidate in India, the report E2B said, citing officials familiar with the matter.Also Read | Revenge of the lambs at the GabbatoirModerna did not respond to Reuters request for a comment outside business hours, while Tata Medical & Diagnostics did not immediately respond.Unlike Pfizer's vaccine, which must be kept at minus 70 degrees Celsius or below, Moderna's can be stored at normal fridge temperatures, making it more suited for poorer countries such as India where cold chains are limited.Data released in November from.